![John DeYoung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John DeYoung
Directeur/Bestuurslid bij
ALLOGENE THERAPEUTICS, INC.
Profiel
John DeYoung is currently an Independent Director at Allogene Therapeutics, Inc. since 2018.
Mr. DeYoung is also Vice President-Worldwide Business Development at Pfizer Inc. since 2009.
Mr. DeYoung completed an undergraduate degree at Michigan State University in 1985.
Mr. DeYoung earned an MBA from The University of Chicago in 1990.
Actieve functies van John DeYoung
| Bedrijven | Functie | Begin |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-04-2018 |
| PFIZER INC. | Corporate Officer/Principal | 01-12-2009 |
Opleiding van John DeYoung
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
94
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
